BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 28
• 29
• 30
• 31

• Drug Development

  Kite Pharma Presents Phase I Results From ZUMA-1 At The 57th American Society of Hematology Annual Meeting

  December 7, 2015

   · 

  5 min read
• Business

  Nemucore Medical Innovations Options Clinical-Stage Aurora Kinase Inhibitor Gsk1070916 From Cancer Research Technology

  December 7, 2015

   · 

  6 min read
• Drug Development

  Ariad Announces Initiation Of OPTIC-2L Randomized Phase 3 Trial Of Ponatinib Vs. Nilotinib In Second-Line Patients With Chronic-Phase Chronic Myeloid Leukemia

  December 7, 2015

   · 

  13 min read
• Drug Development

  Celgene Release: FDA Fast Track Designation Granted To Luspatercept For The Treatment Of Patients With Lower-Risk Myelodysplastic Syndromes

  December 7, 2015

   · 

  6 min read
• Policy

  Health Canada Issues Notice Of Compliance For Gilead’s Single Tabletregimen Genvoya (Elvitegravir, Cobicistat, Emtricitabine And Tenofoviralafenamide) For Treatment Of HIV-1 Infection

  December 7, 2015

   · 

  5 min read
• Drug Development

  Spectrum Pharma And Onxeo Announce Complete Response In 67% Of Patients With Peripheral T-Cell Lymphoma In Combination Of Belinostat (Beleodaq) And Standard CHOP

  December 7, 2015

   · 

  12 min read
• Drug Development

  Takeda Reports Five-Year Overall Survival Data For ADCETRIS(Brentuximab Vedotin) Demonstrate Durable Remissions In Relapsed/Refractory Hodgkin Lymphoma

  December 7, 2015

   · 

  14 min read
• Drug Development

  Celgene Release: Study Of Bortezomib Added To Revlimid And Dexamethasone Backbone Therapy Presented At American Society of Hematology

  December 7, 2015

   · 

  20 min read
• Drug Development

  GlycoMimetics, Inc. Poster Shows GMI-1271 Reverses Drug Resistance In Multiple Myeloma Models

  December 7, 2015

   · 

  3 min read
• Drug Development

  Sunesis Announces Presentation Of Positive Results From MD Anderson Cancer Center Sponsored Trial In AML At American Society of Hematology Annual Meeting

  December 7, 2015

   · 

  6 min read